Mattia Arrigo Selected Research

Mattia Arrigo Research Topics

Disease

15	Heart Failure 02/2022 - 12/2016
4	Cardiogenic Shock 02/2022 - 07/2017
4	Critical Illness (Critically Ill) 01/2020 - 01/2014
3	Atrial Fibrillation 01/2020 - 01/2014
3	Acute Coronary Syndrome 03/2019 - 07/2016
2	Myocardial Infarction 10/2021 - 07/2016
2	Necrosis 01/2021 - 07/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2017
2	Mitral Valve Stenosis (Mitral Stenosis) 01/2020 - 10/2016
2	Water Intoxication 11/2018 - 10/2018
2	Sepsis (Septicemia) 08/2018 - 12/2017
2	Hyperemia 01/2018 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 10/2017 - 01/2017
1	Infections 01/2020
1	Fever (Fevers) 08/2018
1	Tachycardia (Tachyarrhythmias) 08/2018
1	Lethargy 08/2018
1	Septic Shock (Toxic Shock Syndrome) 12/2017
1	Disease Progression 11/2017
1	ST Elevation Myocardial Infarction 07/2016
1	Chest Pain (Chest Pains) 07/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016
1	Dyspnea (Shortness of Breath) 07/2016
1	Edema (Dropsy) 04/2016
1	Acute Kidney Injury (Acute Renal Failure) 06/2015
1	Rupture 06/2015
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2015

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2016
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 07/2016
6	Natriuretic PeptidesIBA 01/2020 - 07/2016
4	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2017
3	AdrenomedullinIBA 03/2019 - 11/2017
2	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 01/2018
2	Atrial Natriuretic Factor (ANF)IBA 01/2018 - 11/2017
2	vernakalantIBA 01/2014 - 01/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	LeptinIBA 01/2021
1	Vascular Endothelial Growth Factor DIBA 01/2021
1	Myeloblastin (Proteinase 3)IBA 01/2021
1	Chitinase-3-Like Protein 1IBA 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	LigandsIBA 01/2021
1	ReninIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2019
1	hydroxide ionIBA 11/2018
1	CytokinesIBA 08/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2018
1	Mineralocorticoid Receptor AntagonistsIBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 12/2017
1	Opioid Analgesics (Opioids)IBA 12/2017
1	Nalbuphine (Nubain)FDA LinkGeneric 12/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2017
1	omega-Chloroacetophenone (Mace)IBA 11/2017
1	N 30IBA 10/2017
1	Tyrosine (L-Tyrosine)FDA Link 10/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2017
1	Placenta Growth FactorIBA 10/2017
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2017
1	Vasodilator Agents (Vasodilators)IBA 12/2016
1	Troponin T (Troponin T1)IBA 07/2016
1	Hemoglobins (Hemoglobin)IBA 04/2016

Therapy/Procedure

5	Therapeutics 02/2022 - 07/2017
2	Critical Care (Surgical Intensive Care) 02/2022 - 10/2021
2	Electric Countershock (Cardioversion) 01/2020 - 11/2015
2	Intraperitoneal Injections 08/2018 - 12/2017
1	Transplantation 10/2021
1	Heart Transplantation (Grafting, Heart) 10/2021
1	Length of Stay 01/2020
1	Analgesia 12/2017
1	Cardiac Resynchronization Therapy 11/2017
1	Prostheses and Implants (Prosthesis) 06/2015
1	Transcatheter Aortic Valve Replacement 06/2015
1	Percutaneous Coronary Intervention 01/2015